Clinical Trial Update: Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Rituximab in acute ST-elevation myocardial infarction (Phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Ischemic Heart Disease, Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED